ScienceCanada1 sourcesNeutral

South Korea streamlines biosimilar review, clinical trials

South Korea is rolling out regulatory changes to speed biosimilar development, including reforms to shorten review timelines, ease phase III trial requirements and simplify oversight of manufacturing changes.

marian chu

via Bioworld

April 7, 2026 | 4:00 PM UTCUpdated 2h ago

Share Read original

Read the full article at Bioworld →

South Korea streamlines biosimilar review, clinical trials

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Bioworld

NewsDataCA

Comments

0 comments

Be respectful and constructive.

Loading comments...

South Korea streamlines biosimilar review, clinical trials

Source Verification

Comments

Ghana Plans Second Paragliding Site in Volta Region by 2027

This NZ winter could get properly cold

Related Articles

A carbon Catch-22: The risks of racing into climate change solutions

The mathematically correct way to slice a pizza

King Charles 'cannot bear' to be in the same room as 1 pet